75F40120R00012_0004.pdf
PDF 22 KB Posted
- Attached to
- NCTR Road & Drainage Improvements Federal contract opportunity
- Solicitation number
- FDA-RFP-75F40120R00012
About this file
This document is an amendment to a solicitation modifying the terms of a federal contract opportunity for road and drainage improvements. It extends the offer due date to November 12, 2020 at 12:00 PM Central Time, and schedules an additional site visit on November 2, 2020 at 9:00 AM Central Time for up to two attendees per contractor who must complete a risk assessment questionnaire. It also moves the question deadline to November 3, 2020 at 12:00 AM Central Time and updates the bid guarantee submission instructions. The opportunity is for road and drainage improvements at the National Center for Toxicological Research in Jefferson, Arkansas per solicitation number FDA-RFP-75F40120R00012 issued by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services.
View the file
Other files for this federal contract opportunity
Show all 30
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
1. CONTRACT ID CODE PAGE OF PAGES
1 2
2. AMENDMENT/MODIFICATION NO.
3. EFFECTIVE DATE
10/29/2020
4. REQUISITION/PURCHASE REQ. NO.
1222085
5. PROJECT NO. (If applicable)
6. ISSUED BY CODE HFT-323 7. ADMINISTERED BY (If other than Item 6) CODE HFT-322
FDA/OO/OFBA/OAGS/DAP
OAGS - Field Operations Branch ATTN: Jennifer Johnson 3900 NCTR Road, Bldg. 50, Rm. 429 Jefferson AR 72079
FDA/OO/OFBA/OAGS/DAP
OAGS - ACQUISITION SERVICES
3900 NCTR ROAD
JEFFERSON AR 72079
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
(x) 9A. AMENDMENT OF SOLICITATION NO.
75F40120R00012 x 9B. DATED (SEE ITEM 11)
10A. MODIFICATION OF CONTRACT/ORDER NO.
10B. DATED (SEE ITEM 13)
CODE FACILITY CODE
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
x The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers x is extended, is not extended.
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing
Items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE
RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR
OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment and is received prior to the opening hour and date specified.
12. ACCOUNTING AND APPROPRIATION DATA (If required)
13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT
ORDER NO. IN ITEM 10A.
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
D. OTHER (Specify type of modification and authority)
E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
1. The purpose of the amendment is to:
a. Extend the "Offer Due Date/Time" to 12:00 pm Central Time (CT), 12 November 2020.
b. Schedule site visit #3 for 9:00 am CT, 02 November 2020.
c. Extend the “Questions” suspense to 12:00 am CT, 03 November 2020.
b. Update Attachment J11 - 75F40120R00012 Section B through M Updates, Part II, Paragraph E on page 42 of 45.
d. Provide Site Visit #2 Minutes. *Attachment 1.
e. Provide Site Visit #2 Questions and Answers. *Attachment 2.
2. All other terms and conditions remain unchanged.
Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
NICHOLAS E. SARTAIN
15B. CONTRACTOR/OFFEROR
(Signature of person authorized to sign)
15C. DATE SIGNED 16B. UNITED STATES OF AMERICA
(Signature of Contracting Officer)
16C. DATE SIGNED
Previous edition unusable STANDARD FORM 30 (REV. 11/2016)
Prescribed by GSA FAR (48 CFR) 53.243
SECTION SF 30 BLOCK 14 CONTINUATION PAGE
The following items are applicable to this modification:
SOLICITATION/CONTRACT FORM
A. The required response date/time has changed from 05 November 2020; 12:00 PM (CT) to 12 November 2020;
12:00 PM (CT).
*Offers shall submit their response in electronic format by email to the Contract Specialist, Jennifer Johnson, at jennifer.johnson3@fda.hhs.gov ensuring “Offer under Solicitation No. 75F40120R00012” appears in the subject line.
B. A site visit (#3) is scheduled for 9:00 AM (CT) on 02 November 2020. Space is limited due to social distancing requirements. Each Contractor is limited to two attendees. Notification of intent to attend plus a completed "Attachment J10-Clinic Risk Assessment Questionnaire for Jefferson Labs (JL)" for each attendee must be sent to Jennifer Johnson at jennifer.johnson3@fda.hhs.gov no later than 12:00 PM (CT) on October 30, 2020.
C. Questions concerning the project are required in writing to jennifer.johnson3@fda.hhs.gov by 12:00 am (CT) on 03 November 2020. *No other questions will be entertained after this suspense date and time.
D. “Attachment J11 - 75F40120R00012 Section B through M Updates”, Part II, Paragraph E on page 42 of 45 has been updated to read: “Bid Guarantee. Submit a bid guarantee in the form of a firm commitment as required by Section L-5 and Section I FAR Clause 52.228-1. Submit bid guarantee to Jennifer Johnson, Contract Specialist, jennifer.johnson3@fda.hhs.gov within 2 business days after solicitation close date”. * Attachment J11 - 75F40120R00012 Section B through M Updates, revised 29 October 2020.
E. Site Visit #2 minutes are provided as “75F40120R00012_0004 Attachment 1 - Site Visit #2 Minutes”.
F. Site Visit #2 questions & answers are provided as “75F40120R00012_0004 Attachment 2 - Site Visit #2 Questions & Answers”.
File details come from the government source that posted it. Updated .